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[42] Receptor-Mediated Transport of D N A into 
Eukaryotic Cells 
By M A T T H E W C O T T E N , E R N S T W A G N E R , and M A X L . B I R N S T I E L 
General Introduction 
DNA-mediated gene transfer into eukaryotic cells has proved to be a 
powerful approach for the analysis of the molecular and cellular biology 
of cell differentiation, growth, and carcinogenic transformation. Many 
techniques have been developed for the introduction of genes: calcium 
phosphate precipitation, 1 , 2 electroporation, 3 , 4 liposome packaging of 
D N A , 5 - 7 w i t h 8 " 1 0 or without specific targeting of the liposomes, D O T M A -
mediated l ipofec t ion , 1 1 1 2 microinjection, 1 3 the use of polycations such as 
1 A. Loyter, G . A. Scangos, and F . H . Ruddle, Proc. Natl. Acad. Sei. U.S.A. 79,422 (1982). 
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Polybrene, 1 4 DEAE-dex t ran , 1 5 - 1 7 lipopolyamine, 1 8 and polyornithine 1 9 as 
well as asbestos-mediated20 or direct transfer of genes from bacteria to eu­
karyotic cells 2 1 or direct microinjection of tissue. 2 2- 2 3 Genes have also been 
transferred by particle bombardment. 2 4 In none of these procedures has the 
mechanism of D N A uptake into the nucleus been thoroughly investigated. 
There are two basic natural mechanisms for the uptake of substances 
in the eukaryotic cell. Small molecules such as amino acids, monosaccha­
rides, and most ions are transported directly across the plasma membrane 
into the cytoplasm. Macromolecules such as peptides and proteins are 
taken up by the process of receptor-mediated endocytosis. This uptake is 
made possible by macromolecule-specific receptors that are found on the 
surface of the cell membrane. Once the macromolecules are bound, ligands 
and receptors are clustered and reach the coated pits on which the clathrin-
associated membrane is pinched off as a coated vesicle. After removal of 
the clathrin the vesicles fuse with and become part of the acidic endo-
somes. Ligand and receptors can have different fates. They can either be 
destroyed in a degradative pathway, or brought back to the cell surface in 
a recycling pathway. Receptors include, among many others, those tar­
geted to low-density lipoprotein ( L D L ) , 2 5 t ransferr in, 2 6 2 7 asialoglycopro-
teins, 2 8 gpl20 envelope protein of the human immunodeficiency virus 
( H I V ) , 2 9 - 3 1 and diphtheria tox in . 3 2 3 3 
1 4 S. Kawai and M. Nishizawa, Mol. Ceil. Biol. 4, 1172 (1984). 
1 5 F . L . Graham and A. J . van der E b , Virology 52, 456 (1973). 
1 6 J . McCutchan and J . S. Pagano, J. Nail. Cancer Inst. 41, 351 (1968). 
1 7 O.-R. B. Choi and J . B. Engel, Cell 55, 17 (1988). 
1 8 J .-P. Behr, B. Demeneix, J.-P. Loeffler, and J . P. Perez-Mutul, Proc. Natl. Acad. Sei. 
U.S.A. 86, 6982 (1989). 
1 9 F . F . Farber, J . L . Melnick, and J . S. Butch, Biochim. Biophys. Acta 420, 298 
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247, 1456 (1990). 
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2 5 J . L . Goldstein, M. S. Brown, R. G . W. Anderson, D. W. Russell, and W. J . Schneider, 
Annu. Rev. Cell Biol. 1, I (1985). 
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Because of the trafficking of the receptors, their internalization 2 7- 2 8 , 3 4 
occurs frequently. Because there are several hundred thousand receptors 
per cell, at least for some ligands, this rapid trafficking leads to high 
turnover numbers per cell. Thus, it has been calculated that each of the 
100,000 to 500,000 asialoglycoprotein receptors on hepatocytes transports 
and internalizes as many as 200 ligand molecules per day. 2 8 Similarly, 
the iron ion-transporting transferrin has high turnover numbers, with an 
estimated 2 χ 104 iron ions transported across the plasma membrane per 
minute. 3 5 
The basic principle of all receptor-mediated transport systems for 
cloned D N A is to subvert the efficient cellular mechanisms of receptor-
mediated internalization of proteins in such a way that ligands bound up 
with D N A are recognized by the receptors and are carried swiftly and 
efficiently across the plasma membrane into the cell. 
Principle of Method 
Transferrinfection is the process by which D N A is transferred into 
cells by transferrin-polycation conjugates based on transferrin-dependent 
receptor-mediated endocytosis. 3 6 - 3 8 For this, the human iron-transport 
protein transferrin, or the chicken homolog conalbumin, was covalently 
linked to D N Α-binding protamines or to DNA-binding polylysines of vari­
ous degrees of polymerization (90 to 450 lysine residues). 
Receptor-Mediated Entry of DNA into Cells. When the plasmid D N A 
in the transferrin-polylysine conjugate (TfpL) complex containing the 
luciferase gene is supplied to eukaryotic cells, moderate to high levels of 
expression of the luciferase gene occurs in some cell types, while others 
3 0 L . A. Lasky, G. Nakamura, D. H . Smith, C . Fennie, C . Shimasaki, E . Patzer, P. Berman, 
T. Gregory, and D. J. Capon, Cell 50, 975 (1987). 
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3 2 R. E . Morris, A. S. Gerstein, P. F . Bonventre, and C . B. Saelinger, Infect. Immun. 50, 
721 (1985). 
3 3 J . M. Rolf, Η. M. Gaudin, and L . Eidels, J. Biol. Chem. 265, 7331 (1990). 
3 4 J . Maddon, J . S. McDougal, P. R. Clapham, A. G . Dalgleish, S. Jamal, R. A. Weiss, and 
R. Axel, Cell 54, 865 (1988). 
3 5 L . Stryer, "Biochemistry," 3rd E d . Freeman, New York, 1988. 
3 6 E . Wagner, M. Zenke, M. Cotten, H . Beug, and M. L . Birnstiel, Proc. Natl. Acad. Sei. 
U.S.A. 87, 3410 (1990). 
3 7 M. Zenke, P. Steinlein, Ε. Wagner, Μ. Cotten, Η. Beug, and Μ. L . Birnstiel, Proc. Natl. 
Acad. Sei. U.S.A. 87, 3655 (1990). 
3 8 M. Cotten, F . Längle-Rouault, Η. Kirlappos, Ε. Wagner, Κ. Mechtler, Μ. Zenke, 
Η. Beug, and Μ. L . Birnstiel, Proc. Natl. Acad. Sei. U.S.A. 87, 4033 (1990). 
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F I G . 1. Diagram summarizing the general principle of transferrinfection. A transferrin-
polycation conjugate is prepared. DNA, when incubated with this conjugate, undergoes 
a polycation-induced condensation to produce a transferrin-coated DNA doughnut. This 
structure is then supplied to transferrin-receptor cells. Transferrin-receptor interactions 
result in the internalization of the complex by receptor-mediated endocytosis. By an unknown 
mechanism, the DNA finds its way to the nucleus, where subsequent expression of genes 
contained on the D N A ensues. 
appear to be refractory (see Table I ) . The general principle of this method 
is summarized in Fig. 1. 
Several lines of evidence suggest that in K562 cells or chicken HD3 
cells receptor-mediated endocytosis of the D N A is involved. Transferrin­
fection is competed by addition of iron-loaded transferrin in the cell 
medium. 3 7 For K562 cells or HD3 cells polylysine alone is a poor carrier 
for D N A transfer into the cel ls . 3 7 , 3 9 Only when linked to the transferrin 
3 9 E . Wagner, M. Cotten, R. Foisner, and M. L . Birnstiel, Proc. Natl. Acad. Sei. U.S.A. 88, 
4255 (1991). 
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moiety does transferrinfection ensue. That the binding of the iron-contain­
ing transferrin to its receptor is a crucial step in transferrinfection is 
further supported by our finding that protocols that increase the number of 
transferrin receptors 3 8 in K562 cells (as determined by Scatchard analysis 4 0 
and our unpublished observations, 1990) also increase transferrinfection. 
The binding of transferrin-polylysine and transferrin-polyly­
s ine-DNA to cell surface receptors was measured with tritiated com­
pounds whereas the internalization was followed using fluoresceinated 
transferrin-polylysine-DNA complexes. Binding of the complexes to via­
ble HD3 cells was saturable. The apparent binding constants were similar 
for transferrin and transferrin-polylysine, suggesting that the polylysine 
moiety did not severely impede receptor recognition. Finally, fluorescein-
labeled transferrin-polylysine-DNA complexes appeared rapidly in nu­
merous small fluorescent vesicles in >95% of the cells, suggesting that the 
D N A complexes were now in the vesicular (endosomal?) system of the 
cel l . 3 7 
We observe that, at least for some cell types, transferrinfection is very 
much enhanced by the addition of chloroquine during the 4-hr duration 
of transferrinfection, but this requirement appears to vary in a highly 
idiosyncratic and unpredictable manner from cell type to cell type. We 
presume that where chloroquine is beneficial, as is the case for K562 
cells, this lysosomatropic drug increases the p H in the endosomal and the 
lysosomal compartments and thus prevents degradation of the reporter 
D N A during passage from endosomes to the nuclear compartment. But 
the action of chloroquine is not fully understood and other mechanisms of 
action are not excluded. Other lysosomatropic substances added with or 
instead of chloroquine, such as monensin, do not facilitate transferrinfec­
tion, but actually interfere with i t . NH 4 C1 and methylamine are ineffective. 
An alternative, and often superior, protocol that allows high-level ex­
pression involves treating transferrinfected cells with a defective adenovi­
rus. In cells that can bind and internalize adenovirus (most human and 
many mouse cell types) the entry of adenovirus involves a membrane 
disruption as the ρ Η drops in the endosome. We have found that treatment 
of cells supplied with various ligand-polycation DNAs (e.g., transfer­
rin-polylysine, gpl20-polylysine, antibody-polylysine) in the presence 
of the replication-defective adenovirus dI312 allows enhanced gene ex­
pression in the absence of chloroquine (see note added in proof). 
Ligands Other Than Transferrin. D N A can be targeted to other recep­
tors by choosing different ligand-receptor systems. Thus, it has been 
4 0 E . Mattia, K . Rao, D. Shapiro, H . Sussman, and R. Klausner, J. Biol. Chem. 259, 2689 
(1984). 
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possible to target the cell membrane protein CD4 in CD4-positive lines 
with conjugates formed between polylysine and anti-CD4 monoclonal anti­
bodies or polylysine and recombinant gp 120 (the envelope protein of H I V ; 
a kind gift of Genentech, South San Francisco, CA). Other receptors were 
targeted with anti-CD7 monoclonal antibodies and asialofetuin (unpub­
lished observations, 1992). A related procedure using asialoorosomu-
coid-polylysine conjugates has been successfully used to deliver D N A , 
via the asialoglycoprotein receptor, to hepatocytes, both in tissue culture 
and in rats . 4 1 , 4 2 
Quantitative Aspects. High D N A concentrations during transferrinfec­
tion are desirable but the D N A concentration in stock solutions cannot 
exceed 20-30 /xg/ml because of the limited solubility of the T f p L - D N A 
complexes. We find that plasmids of 13 kb work as well as plasmids of 6 
kb. We are currently testing alternate D N A packaging schemes to increase 
the size of plasmid that can be reliably transfected. (See note added in 
proof. 5) 
Quantitative Southern analysis revealed that initially, after a few hours 
of incubation, on the order of 5000 ( t l e p i s o m a Γ , ) D N A plasmids per cell 
became associated with K562 cells. One or 2 weeks later the number of 
D N A molecules was reduced by a factor of about 1000. In the case of 
K562 cells, virtually all cells take up D N A (see above) and close to 100% 
of the cells express the reporter gene (see Ref. 37 and below). Especially 
where chloroquine is not required, there is no cell death during transferrin­
fection. This means that the procedure can be repeated several times on 
the same cell culture and in this way the amount of D N A that is transferred 
into the cells can be increased. 3 7 
Where there is no selection for the transferred gene, expression after 
transferrinfection is transient. Expression of the Rous sarcoma virus long 
terminal repeat (LTR)-driven luciferase expression plasmid (pRSVL) in 
K562 cells, after reaching a maximum of expression around 18 to 24 hr, 
decays with a half-life of days when measured in the cell culture as a 
whole. When the pRSVL construct is presented to K562 cells in the 
context of a dominant control region of the globin gene cluster, 4 3 expres­
sion is maximal after day 2 and a high level persists in the cell culture as 
a whole for about 2 to 3 weeks. This protracted expression may render 
the establishment of stable cell lines unnecessary in some distances. When 
transfection of a selectable marker (e.g., neomycin phosphotransferase) 
4 1 C . Wu, J . Wilson, and G . Wu, J. Biol. Chem. 264, 16985 (1989). 
4 2 G . Y . Wu and C . H. Wu, J. Biol. Chem. 263, 14621 (1988). 
4 3 P. Collis, Μ. Antoniou, and F . Grosveld, EMBOJ. 9, 233 (1990). 
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is performed on K562 cells about 0.5 to 1% of the cells form colonies of 
stable transformants. 
Methods 
Synthesis of Transferrin-Polylysine Conjugates 
The initial conjugate synthesis 3 6 3 9 involved the modification of one to 
two amino groups on the transferrin molecule with the reactive afunc-
tional reagent 7V-succinimidyl-3-(2-pyridyldithio)propionate (SPDP), fol-
lowed by the ligation to the similarily modified polycations (polylysine or 
protamine) through the formation of disulfide bonds (see Conjugation 
Method 1, below). We have also synthesized transferrin-polylysine conju-
gates that contain a specific ligation through modification of the transferrin 
carbohydrate moiety. 4 4 The two terminal exocyclic carbon atoms of the 
sialic acids within the carbohydrate chains of human transferrin are selec-
tively removed by periodate oxidation. 4 5 The oxidized aldehyde-con-
taining form of transferrin was used for coupling to the amino groups 
of polylysine. The junction that results from aldimine formation was 
stabilized by reduction with sodium cyanoborohydride to the corres-
ponding amine linkage (see Conjugation Method 2, below). There are a 
number of advantages of the carbohydrate linkage procedure compared 
to the SPDP procedure. The carbohydrate method has the advantage of 
being less time consuming. It is useful for scaling up for the preparation 
of large quantities of conjugates and it generates conjugates having 
defined polycation-transferrin ligation sites with "nature-derived" carbo-
hydrate spacers. 
Preparation of Conjugates 
General Procedures 
Quantitative Assays. The polylysine content of fractions was estimated 
spectrophotometrically by the ninhydrin assay and, in the case of fluores-
cein isothiocyanate (FITC)-labeled polylysine, by absorption at 495 nm. 
The amount of dithiopyridine linkers in modified transferrin was deter-
mined, after reduction of an aliquot with dithiothreitol, by an absorption 
measurement of released pyridine-2-thione at 340 nm. The amount of free 
4 4 E . Wagner, M. Cotten, K . Mechtler, H . Kirlappos, and M. L . Birnstiel, Bioeonjugate 
Chem. 2, 226 (1991). 
4 5 T . Kishimoto and M. Tavassoli, Anal. Bioehem. 153, 324 (1986). 
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mercapto groups was determined using Ellman's reagent4 6 and measure­
ment at 412 nm. Transferrin content of the fractions was determined by 
ultraviolet (UV) measurement at 280 nm and correction (where necessary) 
of the value by subtraction of the corresponding U V absorption of FITC, 
dithiopyridine, or buffer at 280 nm. 
Conjugation Method 1: Transferrin-Polylysine Conjugate Synthesis 
through Disulfide Linkages 
Conjugation method 1 has been used for the preparation of conjugates 
of transferrin or conalbumin with various poly(L-iysines), 3 6 poly(D-lysine), 
poly(L-arginine) (unpublished observations, 1990), salmon sperm prot­
amine, 3 6 and a synthetic protamine analog 3 9; conjugates of poly(L-lysines) 
with rgp l20 4 7 , 4 8 have been synthesized (unpublished observations, 1990), 
as well as poly(L-lysine)-antibody conjugates [with anti-CD4, anti-CD7 
(unpublished observations, 1990)] and with asialofetuin (unpublished ob­
servations, 1990). A related procedure for the synthesis of asialoorosomu-
coid poly(L-lysine) conjugates has been described by Wu and W u . 4 2 
Transferrin-poly(L-lysine) conjugates with polylysines of an average 
chain length of 200 or 450 lysine monomers (pL200, pL450) have been 
synthesized as described 3 6 , 3 9: coupling of transferrin to polylysine was 
performed by ligation via disulfide bonds after modification with the afunc­
tional reagent succinimidyl-3-(2-pyridyldithio)proprionate (SPDP; Phar­
macia, Piscataway, NJ). 
3-(2-Pyridyldithio)propionate-Modified Transferrin. A solution of 100 
mg (1.25 μπιοί) of human transferrin (iron free, Sigma, St Louis, MO) 
in 3 ml of 100 m M N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid 
(HEPES) buffer, p H 7.9, was subjected to gel filtration on a Sephadex G-
25 column. To the resulting 5-ml solution, 260 μΐ of a 10 mM ethanolic 
solution of SPDP (2.6 μτηοΙ) was added with vigorous mixing. After 1 hr 
at room temperature, purification was performed by a further Sephadex 
G-25 gel filtration to give 6 ml of a solution of 1.1 μπιοί transferrin modified 
with 2.1 μπιοί dithiopyridine linker. 
3-Mercaptopropionate-Modified Polylysine. Poly(L-lysine) of different 
molecular weights was used, namely those with an average chain length 
of 200 or 450 lysine monomers ( p L 2 0 0 or p L 4 5 0 hydrobromide; Sigma). 
Both unlabeled and fluorescent-labeled polylysines were used; fluorescent 
labeling with FITC (Sigma) was performed in sodium bicarbonate buffer, 
4 6 G . L . Ellman, Arch. Biochem. Biophys. 82, 70 (1959). 
4 7 L . Lasky, J . Groopman, C . Fennie, P. Benz, D. Capon, D. Dowbenko, G . Nakamura, W. 
Nunes, M. Renz, and P. Berman, Science 233, 209 (1987). 
4 8 L . Lasky, G . Nakamura, D. Smith, C . Fennie, C . Shimasaki, E . Patzer, P. Berman, 
T. Gregory, and D. Capon, Cell 50, 975 (1987). 
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pH 9, for 3 hr. A gel-filtered solution of 0.57 μπιοί p L 2 0 0 (FITC labeled) in 
3 ml 20 m M sodium acetate buffer was brought to pH 7.9 by the addition 
of 300 μΐ of 1 Μ HEPES buffer and 204 μΐ of a 10 m M ethanolic solution 
of SPDP (2.04 μιτιοί) was added with vigorous mixing. One hour later 500 
μΐ of 1 Μ sodium acetate, pH 5, was added; after gel filtration with 20 m M 
sodium acetate the solution contained 0.54 μιτιοί pL 2 0 o with 1.86 μπιοί of 
dithiopyridine linker. The solution was brought to p H 7 by addition of 
HEPES buffer, and 36 mg dithiothreitol (DTT) was added. The solution 
was kept under argon at p H 7.5 for 1 hr. The p H was adjusted to 5.2 by 
addition of 400 μΐ 3 Μ sodium acetate buffer. After gel filtration (Sephadex 
G-25, 14 x 180 mm column, 15 m M sodium acetate, pH 5.0) a solution of 
0.50 μπιοί p L 2 0 0 , which was modified with 1.84 μπιοί mercaptopropionate 
linker, was obtained. Following the same procedure, modification of 0.20 
μπιοί p L 4 5 0 with 0.70 μιτιοί SPDP gave a product of 0.18 μπιοί p L 4 5 0 with 
0.57 μιτιοί dithiopyridine groups; treatment with DTT and isolation gave 
0.175 μπιοί p L 4 5 0 modified with 0.56 μπιοί mercapto groups. 
Conjugation of Transferrin with Polylysine. T f p L 2 0 0 conjugates were 
prepared by mixing 1.06 μιτιοί modified transferrin (see 3-(2-Pyridyldithio)-
propionate-Modified Transferrin, above) in 100 m M HEPES buffer, p H 
7.9, with 0.20 μπιοί modified p L 2 0 0 (see previous section) in sodium acetate 
buffer under an argon atmosphere. The reaction mixture was kept for 18 
hr at room temperature. T f p L 4 5 0 conjugates were prepared in a similar 
manner starting with 0.61 μπιοί modified transferrin and 0.12 μιτιοί mercap-
to-modified p L 4 5 0 . 
Both T f p L 2 0 0 and T f p L 4 5 0 were isolated from the reaction mixture by 
cation-exchange chromatography [Pharmacia Mono S column HR 10/10; 
gradient elution, buffer A: 50 m M HEPES (pH 7.9) and buffer B: buffer 
A plus 3 Μ sodium chloride]; it was essential for the recovery of the 
polycation conjugates to add sodium chloride to the reaction mixture (final 
concentration, 0.6 Μ in case of T f p L 2 0 0 or 1 Μ in case of T f p L 4 5 0 conjugates) 
before loading the column and to start the gradient at this salt concentra­
tion. The excess of uncoupled transferrin was eluted first. The product 
fractions were eluted at salt concentrations around 1.4 Μ with T f p L 2 0 0 or 
around 2 Μ salt with T f p L 4 5 0 . The T f p L 2 0 0 product fractions were pooled 
into three conjugate fractions, A - C , with increasing polylysine: trans­
ferrin ratio. The T f p L 4 5 0 conjugates were separated into four fractions, 
Α - D . After dialysis against HBS [20 m M HEPES (pH 7.4), 150 m M NaCl], 
conjugate fractions were obtained with overall yields of 80% ( T f p L 2 0 0 , 
containing 39 mg conjugated transferrin) or 64% ( T f p L 4 5 0 , containing 20 
mg conjugated transferrin). The yields are based on equivalents of transfer­
rin in the product relative to equivalents of mercapto groups in the modified 
polylysine starting material. 
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Conjugation Method 2: Transferrin-Polylysine Conjugate Synthesis 
through Carbohydrate Modification 
Conjugation method 2 has been applied to the synthesis of transfer-
rin-polylysine conjugates,4 4 for the conjugation of rgpl20 to polylysine 
(unpublished observations, 1992), and for the conjugation of transferrin 
to a synthetic protamine analog or to the D N A intercalator ethidium 
homodimer. 4 4 However, the method could not be used for the preparation 
of conalbumin-polylysine conjugates, 3 6 , 4 4 probably due to the absence of 
sialic acid residues in the conalbumin carbohydrate. 4 9 
A solution of 102 mg (1.28 μπιοί) of transferrin (human, iron-free; 
Sigma) in 3 ml of a 30 m M sodium acetate buffer (pH 5) was subjected 
to gel filtration on a Sephadex G-25 (Pharmacia) column. This gel-
filtration step serves to remove low molecular weight contaminants that 
interfere with the modification steps. The resulting 3.8-ml solution was 
cooled to 0° and 80 μΐ of a 30 m M sodium acetate buffer (pH 5) 
containing 4 mg (19 μιτιοί) of sodium periodate was added. The mixture 
was kept in an ice bath in the dark for 90 min. For removal of the low 
molecular weight products, a further gel filtration (Sephadex G-25, 30 
m M sodium acetate buffer, pH 5) was performed and yielded a solution 
containing about 82 mg (1.03 μπιοί) of oxidized transferrin {monitoring: 
U V absorption at 280 nm and ninhydrin assay; the oxidized form that 
contains aldehydes in contrast to unmodified transferrin, gives a color 
reaction on staining with anisaldehyde reagent [a sample is dropped on 
a silica gel thin-layer plate, dried, immersed into p-anisaldehyde/sulfuric 
acid/ethanol (1/1/18, v/v/v) and followed by drying and heating]}. The 
transferrin solution was added to a solution containing 0.50 μιτιοί of 
fluorescently labeled poly(L-lysine) with an average chain length of 300 
lysine monomers [derived from 34 mg hydrobromide salt (Sigma) after 
labeling with 130 μg of fluorescein isothiocyanate in sodium bicarbonate 
buffer (pH 9) for 3 hr and subsequent gel filtration] in 4.5 ml of 100 
mM sodium acetate (pH 5) with vigorous mixing at room temperature. 
The pH of the solution was brought to 7.5 by addition of 1 Μ sodium 
bicarbonate after 20 min; to the mixture, four portions of 9.5 mg 
(150 μιτιοί) of sodium cyanoborohydride were added at 1-hr intervals. 
Purification proceeded in the same fashion as described in conjugation 
method 1: after 18 hr of reduction, 1.9 ml of 5 Μ sodium chloride was 
added to bring the solution to an overall salt concentration of about 
0.75 M . The reaction mixture was loaded on a cation-exchange column 
(Pharmacia Mono S HR 10/10) and was fractionated with a sodium 
chloride gradient from 0.75 to 2.5 Μ with a constant content of 25 m M 
4 9 J . Williams, Biochem. J. 108, 57 (1968). 
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HEPES (pH 7.3). Some transferrin protein (about 30%) together with 
a weak fluorescence activity eluted in the flow-through; the major 
amount of fluorescent conjugate eluted between 1.35 and 1.9 Μ salt and 
was pooled into three fractions. After dialysis twice against 2 liters of 
25 m M HEPES (pH 7.3), these yielded (in order of elution) fraction A, 
containing 19 mg (0.24 μιτιοί) of transferrin modified with 80 nmol of 
polylysine; fraction B, containing 27 mg (0.34 μ,πιοί) of transferrin 
modified with 150 nmol of polylysine; and fraction C, containing 5 mg 
(62 nmol) of transferrin modified with 80 nmol of polylysine. The overall 
yield of these conjugates based on transferrin was 50%, based on 
polylysine (62%). 
Storage of Conjugates and Iron Incorporation for 
Transferrin Ligands 
Transferrin conjugates, unless used immediately, can be stored after 
shock-freezing (liquid nitrogen) at - 2 0 ° for up to 12 months in the iron-
free form. Before iron incorporation, samples (about 0.5 to 1.5 mg) are 
brought to physiological salt concentration (150 mM) by the addition of 
sodium chloride; the iron incorporation is performed by the addition of 4 
to 8 μΐ of 10 m M iron(III)-citrate buffer (containing 200 m M citrate and 
adjusted to p H 7.8 by sodium bicarbonate addition) per milligram transfer­
rin content. The iron-loaded conjugates are used for D N A complex forma­
tion as described (see Conjugate DNA-Complex Formation). To limit the 
deterioration of the conjugates that often occurs on several freeze-thaw 
cycles, the conjugates are divided into convenient small aliquots, shock-
frozen, and kept at - 2 0 ° . In general, iron-incorporated samples maintain 
their transfection activity for 2-3 months i f repeated freeze-thaw cycles 
are avoided. 
Application of Conjugates 
Choice of Cells 
We have tested a variety of cells for their ability to be transfected with 
transferrin-polycation conjugates. These results are summarized in Table 
I . The cell types fall into three categories based on the luciferase activity 
obtained. Luciferase expression appears to be a good general indicator of 
gene expression. We have tested other parameters of gene transfer such 
as RNA production by both class I I and class I I I polymerase, generation 
of ß-galactosidase protein, generation of tat trans-activation with an H I V 
L T R system, and generation of stable cell lines expressing neomycin 
phosphotransferase. The values obtained are consistent with luciferase 
values. 
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T A B L E I 
T R A N S F E R R I N F F X T I O N W I T H V A R I O U S C E L L T Y P E S 
Efficiency 
Cell type of transfection" 
Cells that work well (>10 5 light units/106 cells) 
Human K562 cells + 
Human Ewing's sarcoma EW-2 cells + 
Chicken HD3 erythroblasts -
Chicken R E V - N P B 4 lymphoblasts 
Cells that work moderately well (5 χ 103 to 10s 
light units/106 cells) 
Human H e L a cells -
Human HepG2 cells + 
Human H9 cells + 
Hamster C H O cells 
Mouse Ehrlich ascites + 
Monkey C O S cells + 
Rat H4IIEC3 cells + 
Rat 1A cells 
Chicken EGFR-myb erythroblasts 
Chicken normal bone marrow cells -
Cells that work poorly (<10 3 light units/106 cells) 
Human primary lymphocytes 
Human U937 cells 
Human Kurkatt cells 
Human C C R F C E M cells 
" + , Works only with chloroquine; - , works without or with chloro­
quine. 
Also indicated in Table I is the requirement of each cell type for 
chloroquine (100 μΜ) during the 4-hr transfection period. 
Preparation of Cells, Treatment to Enhance Transferrin 
Receptor Levels 
Transfection of Suspension Cultures. In general, exponentially growing 
suspension cultures are collected by centrifugation and suspended in fresh 
medium (with or without serum; see below) at one-third to one half of 
their saturating density. For example, K562 cells are grown in suspension 
in RPMI1640 medium [Cat. No. 079-03018P(GIBCO—Bethesda Research 
Laboratories, Gaithersburg, M D ) , plus 2 g sodium bicarbonate per liter] 
plus 10% (v/v) fetal calf serum (FCS) 100 units/ml penicillin, 100 μ&π\ 
streptomycin, and 2 m M glutamine, reach a density of 500,000 cells/ml. 
At 12-20 hr before transfection, the cells are placed in fresh medium 
containing 50 μΜ desferrioxamine [D 9533 (Sigma); stock solution is dis-
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solved in water at 100 m M , and stored in aliquots at - 2 0 ° ] . The morning 
of the transfection, the cells are collected, resuspended in fresh medium 
containing 10% (v/v) FCS (plus 50 μΜ desferrioxamine) at 250,000 cells/ 
ml, and placed in a 24-well dish at 2 ml/well . 
The desferrioxamine pretreatment serves to raise the transferrin recep­
tor levels approximately fivefold, resulting in an increase in D N A deliv­
ery. 3 8 With some cell types, such as chicken HD3 cells, exponential growth 
alone produces high transferrin receptor levels that cannot be further 
elevated by desferrioxamine treatment. A n enhancement of gene delivery 
is observed in HD3 cells only when stationary cultures are treated with 
desferrioxamine. This parameter should be evaluated when testing a new 
cell type. 
Transfection of Adherent Cells. In general, cells are transfected at 
50-60% confluence to ensure that a large proportion of cells are dividing 
and wil l continue to divide during the experiment. The cells [e.g., HeLa, 
Chinese hamster ovary (CHO), HepG2] are plated on day 1 
(300,000-600,000 cells/T-25 flask, having an approximately 25-cm2 surface 
area) and transfected on either day 2 or day 3. On the morning of the day 
of transfection, the cells are placed in 5 ml of fresh medium per T-25 flask. 
Application of the Transferrin-Polylysine-DNA Complex. Transfer-
r in-polylys ine-DNA complexes are prepared as described below. Nor­
mally 6-10 μg of D N A is used for a sample of 500,000 K562 cells, or a 
sample of 1 million HeLa cells. Just prior to transfection, chloroquine, 
when required, is added so that the final concentration in the cell suspen­
sion plus the D N A solution is 100 μΜ. [Chloroquine is obtained from 
Sigma (C-6628); a stock solution of 100 m M water is stored in aliquots at 
- 2 0 ° in the dark]. Transferrin-polylysine-DNA complex (in 500 μ\) is 
then added for a 4-hr incubation at 37°. The DNA-containing medium is 
then removed, the cells are washed once with 3 ml warmed medium, and 
then 10 ml of warmed medium is added to the cells. When chloroquine is 
not required, the cells are simply incubated in the presence of the DNA 
complex until harvest (additional medium or serum may be added i f neces­
sary). Normally the cells are harvested (see Harvesting Cells, below) 
18-48 hr later and processed for the luciferase (or other) assay. 
DNA Preparation, Precautions, and Quantitation 
D N A quality is an important parameter. We normally purify the D N A 
by two CsCl gradients followed by an RNase and a proteinase Κ digestion, 
phenol-chloroform extraction, and ethanol precipitation. Probably the 
critical parameter is the quantitation of the D N A . The transfection effi­
ciency varies strongly with the D N A : TfpL ratio, therefore errors in 
D N A quantitation can influence the transfection. R N A can also bind the 
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polylysine and compete for D N A binding, as well as contribute to the 
absorbance at 260 nm. It seems important to have a reliable D N A quantita­
tion in the absence of RNA for good transfections. 
Plasmid D N A is isolated from the appropriate bacterial strains using a 
Triton/lysozyme lysis method. The bacterial pellet from a 1-liter overnight 
culture is suspended in 10 ml of 20% (w/v) sucrose, 50 m M Tris, 10 m M 
ethylenediaminetetraacetic acid (EDTA), pH 7.5 (solution 1) and placed 
on ice for 10 min. Then 2.2 ml of freshly made 10-mg/ml lysozyme in 
solution 1 is added to the sample, and the samples are vortexed and 
incubated for 10 min on ice. Five milliliters of 0.2 Μ EDTA, pH 7.0, is 
added to the sample, and the sample is again vortexed and incubated on 
ice for 10 min. Ten milliliters of 2% (v/v) Triton X-100, 40 m M Tris, 60 
m M EDTA, p H 7.5 is added to the sample; the sample is mixed thoroughly 
and incubated for 15-30 min on ice. The sample is then centrifuged [45 min, 
17,000 rpm, Sorvall (Norwalk, CT) SS-34 rotor, 4°]. To the supernatant (26 
ml) is added 28.5 g of CsCl and 0.5 ml of a 10-mg/ml solution of ethidium 
bromide and the sample is centrifuged for 16 hr at 49,000 rpm at 20° in a 
Beckman (Fullerton, CA) VTi50 rotor. The supercoiled plasmid band (the 
lower band) is removed from the gradient with a syringe and needle, 
transferred to a VTi65 tube, and centrifuged for 4 hr at 65,000 rpm at 20° 
in a Beckman VTi65 rotor. The plasmid band is recovered from the tube, 
extracted with CsCl-saturated 2-propanol until the pink color vanishes, 
and dialyzed overnight against a 1000-fold excess of 10 m M Tris, 1 m M 
E D T A , p H 7.4 (TE). The D N A is then recovered by ethanol precipitation, 
treated with 0.2 mg/ml RNase A (37°, 30 min) followed by 0.2 mg/ml 
proteinase Κ (56°, 30 min). Following a phenol-chloroform and then chlo­
roform extraction, the D N A is again recovered by ethanol precipitation, 
dissolved in TE , and quantitated by triplicate absorbance readings at 260 
nm. A n absorbance at 260 nm of 1 is taken to be 0.05 mg/ml. 
To test the requirement for the CsCl purification steps, parallel samples 
of D N A were prepared. One set was carried through both CsCl gradients, 
the second set, after bacterial lysis, was purified by two phenol-chloro­
form and one chloroform extraction, precipitated at room temperature 
with 0.54 vol 2-propanol (to remove a large portion of the RNA) , and then 
subjected to the RNase A and proteinase Κ steps (referred to hereafter as 
quick D N A ) . Analysis of the D N A samples by gel electrophoresis revealed 
no detectable differences in D N A quality between the CsCl-purified D N A 
and the quick D N A . The two sets of D N A samples were then transferrin-
fected into K562 cells and the subsequent luciferase activity was assayed 
20 hr later (Fig. 2; methods described below). We find large differences in 
the luciferase activity obtained. With the plasmid pRSVL (the Rous sar­
coma virus long terminal repeat driving the luciferase gene), the CsCl-
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Plasmid Preparation Light Units 
pRSVL Quick 1 ii 178305 
pRSVL CsCl 2 ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H 55631 90 
pCMVL Quick 3 ^ ^ ^ ^ ^ ^ ^ ^ ^ 2502480 
pCMVL CsCl 4 ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H 15456605 
·—'» » t r i T T T τ - ι > r π ι ι , τ . ι ι ι . ι . 
1 0 5 1 0 6 1 0 7 1 0 8 
F I G . 2 . Influence of DNA quality on transferrinfection. Plasmid DNA was prepared using 
either a quick lysis technique or by two CsCl density gradients as described in text. Aliquots 
of 6 μg DNA were transferrinfected into 5 x K P K 5 6 2 cells (desferrioxamine treated) in the 
presence of 100 μΜ chloroquine and harvested for luciferase analysis 20 hr later. The results 
(plotted as total luciferase light units obtained from each transfected culture) were obtained 
with either the Rous sarcoma virus LTR-driven luciferase expression plasmid, p R S V L 
[J. R. de Wet, Κ. V . Wood, M. DeLuca, D. R. Helinski, and S. SubramanL Mol. Cell. Biol. 
7, 725 (1987)] , or a plasmid containing luciferase driven by the cytomegalovirus immediate 
early promoter ( p C M V L ) . 
purified D N A gives a 31-fold increase in activity; with p C M V L (the cyto­
megalovirus promoter driving the luciferase gene) there is a sixfold in­
crease in expression with the CsCl purification. 
Conjugate-DNA Complex Formation 
Formation of DNA Complexes. Because of its cationic properties, 
the transferrin-polylysine (or the transferrin-protamine) conjugate binds 
D N A avidly. In band-shift experiments it has been demonstrated that the 
transferrin-polylysine conjugates (TfpL) band-shift linear or covalently 
circular D N A without size discrimination. 3 6 For each TfpL preparation, 
one can calculate the mass ratios at which the DNA-transferr in-polyly-
sine mixture reaches electroneutrality. Consistent with this calculation 
one finds nearly complete gel-mobility retardation of the DNA complex 
as well as optimal D N A expression for a reporter gene at these ratios (see 
Ref. 36). 
The formation of complexes of transferrin-polycation with D N A is 
performed by mixing diluted solutions of D N A (30 /xg/ml or less) with the 
transferrin-polycation conjugates. Normally we dilute the D N A (as a 0.5 
to 1.5-mg/ml solution in TE) into HBS, with a resulting volume of 330 μ\. 
The dilution of D N A at room temperature and the absence of phosphate 
in the buffer are essential to avoid precipitation problems. In a second 
tube, TfpL is diluted into HBS (final volume, 170 μ\). The 170-/xl TfpL 
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sample is then rapidly mixed with the 330-μ1 D N A sample to generate the 
DN A - T f p L complex ready to add to the cells. The optimum weight ratio 
of T fpL (as transferrin) to D N A is normally determined in titration experi­
ments in which a constant amount of D N A encoding a reporter gene, 
6 ^ g , is complexed with 12-24 /xg of TfpL and tested for transfection 
efficiency. 
Investigations have shown that the polycation-polylysine in the trans-
ferrin-polycation conjugates not only serves to attach transferrin to D N A , 
but also plays a pivotal role in condensing the D N A to toroid-like struc­
tures with a diameter of about 80—100 nm, 3 9 a dimension that resembles 
the diameter of the coated pits. 
We have investigated the role of D N A condensation in transferrinfec­
tion efficiency in K562 cells using the luciferase gene (pRS V L ; size: 6.2 kb) 
as a reporter gene. We find that although authentic or synthetic protamines 
conjugated to T f bind D N A and function in D N A delivery, no condensed 
toroid structures can be found by inspection in the electron microscope. 
Consistent with this lack of D N A condensation we find that the gene 
transfer is down by at least a factor of 10 as compared to the TfpL system. 
Polylysine by itself condenses D N A to doughnut-like structures, a finding 
first reported for λ D N A by Laemmli , 5 0 but no D N A transfer is observed 
in K562 ce l l s . 3 7 3 9 
The ratio of transferrin to polylysine in the conjugate also influences the 
efficiency of transferrinfection. After conjugation, fractions with differing 
transferrin : polylysine ratios can be isolated by chromatography on Phar­
macia Mono S columns 3 9 and their efficiency of transferrinfection tested. 
Using the luciferase gene as a reporter gene it emerges that conjugation 
of 1 transferrin per approximately 100 lysine moieties yields optimal com­
pounds for gene transfer experiments. 
Conjugate-Free Polycation-DNA Ternary Complexes 
With conditions that maximize transferrinfection, a calculated 120 
transferrin molecules are associated with each 6 kb of plasmid D N A . We 
have noted that a large fraction, up to 90% of the TfpL, can be replaced 
by polylysine or the metabolically stable poly(D-lysine) without impeding 
doughnut formation or transferrinfection. However, i f the number of trans­
ferrin molecules per doughnut falls below 10-15, targeting of the com­
plexes to the receptors is apparently no longer possible and transferrinfec­
tion is abolished. Condensation of the D N A , with various degrees of 
success, can be brought about by cations such as histones and protamines, 
but not with spermidine or spermine (at physiological ionic strength). 
5 0 U . K . Laemmli, Proc. Natl. Acad. Sei. U.S.A. 72, 4288 (1975). 
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With the exception of histone H4, a strong correlation between D N A 
condensation and transferrinfection efficiency has been found. 3 9 
Transfection, Troubleshooting, Initial Parameters to Vary 
The presence or absence of fetal calf serum (FCS) in the transfectiom 
medium may have an effect on the transferrinfection efficiency. Depending 
on a particular batch of FCS (different quality and origin), with K562 celhs 
we sometimes find a higher initial transfection rate (day 1) i f we omit serumi 
from the medium during the first 4 hr of transferrinfection. However;, 
cells suffer considerably from this serum-free period in the presence 0 ) f 
chloroquine. In contrast, more than 99% of cells stay viable when botlh 
FCS and chloroquine are included in the transfection experiments; conse--
quently at a later time point (day 2) the gene expression of the whoke 
culture is higher. 
There are a number of other parameters that can be varied to improwe 
the transfection efficiency. However, the initial parameters that we tesst 
when evaluating a new cell type are the use of 100 μΜ chloroquine anod 
the presence of serum during the 4-hr D N A exposure. In general we uisne 
a human transferrin in our conjugates, so that competition with bovinae 
transferrin (in the fetal calf serum) is generally not a problem when trans s-
fecting human cells. However, the competition effect may be strongeer 
when the human transferrin conjugate is used to transfect mouse cells, raat 
cells, or cells of other species. Although it should not influence the D M / A 
delivery, the promoter used to drive the indicator gene plays an importainnt 
role. I f the promoter driving the indicator gene has weak activity in the c ebll 
type being tested, it wil l obviously influence the resulting gene expressions 
Standard Transfection Protocol for K562 Cells 
K562 cells are prepared for transfection (as described in Receptonr-
Mediated Entry of D N A into Cells, above) at 250,000 cells/ml, and place<ed 
in a 24-well dish at 2 ml/well . 
Six micrograms D N A in 330 μ\ HBS (150 m M NaCl, 20 m M HEPESS, 
pH 7.3) is mixed with TfpL conjugate (optimum, e.g., 18 /xg in the case oof 
T f p L 3 0 0 B ) in 170 μΐ HBS, and after 15 to 30 min at room temperature t;h<he 
mixture is added to K562 cells. Chloroquine is added to the 2-ml oelell 
sample just before adding the 500-μ1 DNA-conjugate sample (100 μΜ finaial 
concentration; 25 μ\ of a 10 m M chloroquine solution is added). Afteir r a 
4-hr incubation at 37°, the cells are washed in prewarmed, fresh mediumim 
(no chloroquine) and incubated at 37°. (Normally this is done by gentthly 
removing 90% of the medium and replacing it with fresh medium, followeied 
by a repetition after waiting an hour to let the cells resettle.) 
An analysis of the optimum time for exposure of K562 cells t< to 
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F I G . 3. D N A delivery as a function of the time of exposure to transferrin-polylysin-DNA 
complexes. Transferrinfection was performed with 6 μ% p R S V L and 5 χ ΙΟ5 K562 cells 
(desferrioxamine treated) in the presence of 100 μΜ chloroquine. The cells were exposed to 
the D N A for the indicated times, washed with fresh medium, and assayed for luciferase 
activity 20 hr later. 
T f p L - D N A complexes in the presence of 100 μΜ chloroquine is shown 
in Fig. 3. K562 cells were incubated with 6 μ-g pRSVL as a complex with 
18 μ% of TfpL, in 100 μΜ chloroquine. After the indicated times, the 
cells were washed into fresh medium lacking chloroquine. The cells were 
harvested 20 hr later, and extracts were prepared and analyzed for lucifer­
ase activity. We find that the highest levels of expression are obtained 
when the cells are exposed to the D N A complexes for 4 hr (Fig. 3). 
Subsequent experiments indicate a decline in cell viability after 5 hr (proba­
bly due to the toxicity of the chloroquine) so that in general, when chloro­
quine is required, the incubation time is limited to 4 hr. In cells where 
chloroquine is not required (chicken HD3, some HeLa lines) the cells can 
be kept in constant exposure to T f p L - D N A complexes with no apparent 
change in cell viability. 
Harvesting Cells 
The cells are normally harvested for luciferase assay 16 to 20 hr after 
transfection (see below and Assays for Transfection Efficiency). However, 
the timing of harvest is an important variable and should be optimized in 
initial experiments. In general, harvest at 24-48 hr after transfection gives 
a good yield of activity. 
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F I G . 4. Luciferase activity as a function of the time of harvest. Transferrinfection was 
performed with 6 μ-g p R S V L and 5 x ΙΟ5 K562 cells (desferrioxamine treated) in the presence 
of 100 μΜ chloroquine and in either the presence or absence of 10% (v/v) fetal calf serum. 
After a 4-hr exposure to DNA, the cells were washed with complete medium and harvested 
either 24, 48, or 72 hr later. The graph indicates the resulting luciferase activity (in light 
units). 
An analysis of the optimum harvest time for assaying luciferase expres­
sion in K562 cells is shown in Fig. 4. K562 cells were transferrinfected 
with 6 μg of pRSVL in either the presence or absence of 10% (v/v) fetal 
calf serum. Cells were harvested at various times after transfection, and 
extracts were made, standardized for protein content, and assayed for 
luciferase activity (Fig. 4). When transfected in the absence of serum, the 
yield of luciferase activity peaks at 24 hr and declines by a factor of 
approximately 10 over the next 72 hr (Fig. 4). The expression pattern 
obtained when the transfection is performed in the presence of serum is 
slightly altered, with activity peaking at 48 hr posttransfection (Fig. 4). 
Note that the plasmid used here, pRSVL has no replication signal. Strik­
ingly different results are obtained when a plasmid with the capacity to 
replicate, such as an episome, is used [see Fig. 5, fluorescence-activated 
cell sorting (FACS) analysis]. 
Assays for Transfection Efficiency 
Luciferase Assay 
Suspension Cultures. Transfected cell cultures (2-5 ml, 500,000 to 2 
million cells) are transferred to 15-ml conical tubes, harvested by centrifu-
gation (1500 rpm, Heraeus minifuge, Kalkberg, Germany), resuspended 
in 10 ml of phosphate-buffered saline (PBS), again centrifuged, and the 
cell pellet is transferred to a 1.5-ml Eppendorf tube with 1 ml of PBS. The 
cells are centrifuged in the Eppendorf 5415 centrifuge (14,000 rpm, 20 sec); 
the resulting cell pellet is resuspended in 100 μ,Ι 0.25 Μ Tris, pH 7.5. 
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Control 
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F I G . 5. F A C S analysis to determine the proportion of the transfection population that 
expresses a transfected lacZgene. Transferrinfection was performed with desferrioxamine-
treated K562 cells using (per 5 χ 105 cells) 8 jug of p N E B O . L T R M c Z [containing the 
E p s t e i n - B m virus ( E B V ) EBNAl gene and o n Ρ sequence plus the UwZ gene driven by the 
H I V L T R ] and 2 μ% pCMVTat (containing the HIV tat gene driven by the C M V immediate 
early promoter; both plasmids supplied by Genentech). The transferrinfection was performed 
for 4 hr in RPMI containing 10% (v/v) F C S , 100 μΜ chloroquine, and 50 μΜ desferoxamine. 
Cells were harvested at (A) 24 hr, (B) 48 hr, and (C) I week posttransfection, loaded with 
the fluorescent /3-galactosidase substrate F D G , and analyzed by F A C S . 
Adherent Cultures. The medium is removed from the culture (approxi­
mately 2 million cells, T-25 flask) and the cells are washed once with 5 ml 
of PBS. A 1-ml aliquot of PBS is then added to the flask, and the cells are 
removed from the plastic by gentle scraping with a rubber policeman and 
transferred to a 15-ml conical centrifuge tube. The flask is washed/scraped 
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once more with a 1-ml aliquot of PBS. The cells are collected by centrifuga-
tion, resuspended in 1 ml of PBS, and transferred to an Eppendorf tube; 
after centrifugation the resulting pellet is resuspended in 100 μΐ of 0.25 Μ 
Tris, pH 7.5. 
Extract Preparation. The cells (suspended in 0.25 Μ Tris) are subjected 
to three freeze-thaw cycles (3 min in liquid nitrogen or a dry ice-ethanol 
bath, 3 min in a 37° heating block). The sample is then centrifuged for 5 
min at 15,000 rpm in an Eppendorf 5415 centrifuge and the supernatant 
(containing the luciferase activity) is carefully removed to a fresh centri­
fuge tube. Such extracts can be flash frozen with liquid nitrogen and stored 
at - 2 0 ° or used immediately for luciferase activity determination. There 
are reports in the literature that a Triton lysis method can be used to 
generate luciferase extracts. 5 1 When we have compared the two methods 
(freeze-thaw versus Triton) we have found no great difference in the yield 
of extracted luciferase with K562 cells. However, other cell types may 
show differences in luciferase extractability. 
Determining Luciferase Activity. The luciferase activity in cell extracts 
is assayed using a Berthold CliniLumat instrument (LB 9502, Wildbad, 
Germany) as follows: 
1. Prepare an assay buffer: 
Assay buffer (for 10 ml): 6.85 ml water, 2.5 ml 0.1 Μ glycylglycine (pH 
7.8), 0.5 ml 0.1 Μ ATP, 0.15 ml 1.0 Μ M g S 0 4 
This buffer is prepared fresh on the day of assay to avoid deterioration 
of the ATP. 
2. Prepare an injection buffer: 
Injection buffer (10 ml): 6.0 ml water, 2.0 ml 1 m M luciferin (in water), 
2.0 ml 0.1 Μ glycylglycine (pH 7.8) 
The ATP is from Boehringer Mannheim (Mannheim, Germany; #519 
979, M r 605.2) and a 0.1 Μ solution is obtained by dissolving 605 mg in 10 
ml water. This is stored in aliquots at - 2 0 ° . 
Luciferin is from Sigma (D-luciferin, sodium salt; #L-6882, M r 302.3). 
A 1 m M solution is prepared by dissolving 10 mg luciferin in 33 ml water. 
This is stored in aliquots at - 2 0 ° . 
A luciferase enzyme standard is prepared from luciferase (Sigma, # L -
5256) dissolved at 1 mg/ml in 0.1 Μ glycylglycine, p H 7.8, and stored at 
- 2 0 ° . Various dilutions of the enzyme are prepared in 100 m M sodium 
phosphate (pH 7.5), 10 m M KCl 1 mM M g C l 2 , 1 m M DTT containing 20 
/xg/ml bovine serum albumin (BSA) and are stable at 4° for 1-2 weeks. 
5 1 O. Schwartz, J . Virelizier, L . Montagnier, and U . Hazan, Gene 88, 197 (1990). 
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The luciferase assay is performed by adding 1-50 μΐ of cell extract to 
350 μ\ of assay buffer. The sample is gently mixed (avoid vortexing, which 
may generate a static charge on the tube) and placed in the CliniLumat 
instrument. The instrument automatically injects 300 μΐ of the injection 
buffer into the sample, measures the light emission, and displays an inte­
grated value for the first 30 sec of light production. In general, 1 μΐ of 1 
^g/ml luciferase gives approximately 10 million light units with these assay 
conditions. 
ß-Galactosidase Assay 
We have tested three different /3-galactosidase assay systems. The in 
situ assay procedure, using the chromogenic substrate X-Gal, has proved 
to be an insensitive, unreliable indicator of total cell expression with even 
clonal lacZ expressing lines staining in a chimeric pattern (see also Ref. 
52). Therefore we describe here a solution assay for lacZ activity, useful 
for determining total population activity, and a FACS assay that is useful 
for determining what proportion of a transfected population expresses the 
introduced D N A . 
Analysis of Cell Extracts. Extracts are prepared as described (see 
above) and /3-galactosidase activity was assayed as described by Herbo-
mel et α/. 5 3 One milliliter of a solution containing 60 m M N a 2 H P 0 4 , 40 
m M N a H 2 P 0 4 , 10 m M K C l , 1 m M M g C l 2 , and 50 m M 2-mercaptoetha-
nol, and 0.2 ml of o-nitrophenyl-/3-D-galactopyranoside [ONPG (Sigma), 
2 mg/ml in 60 m M N a 2 H P 0 4 , 40 m M N a H 2 P 0 4 ] were added to 30 μ\ 
of cell extract. The mixture was kept at 37° for 20 min to 1 hr, until 
a yellow shade was obvious (for the extracts with /3-galactosidase 
activity). The reaction was stopped by adding 0.5 ml of 1 Μ sodium 
bicarbonate. /3-Galactosidase activity was determined by measuring the 
absorbance at 420 nm. 
Fluorescence-Activated Cell Sorter Analysis. Living cells were loaded 
with FDG (fluorescein di-/3-D-galactopyranoside) by osmotic shock, di­
luted in staining medium, and processed by FACScan (Becton Dickinson, 
Paramus, NJ) as described. 5 4 
Suspension cell cultures (2-5 ml, 1 million cells) are transferred to 15-
ml conical tubes, harvested by centrifugation (1500 rpm, 10 min, Heraeus 
minifuge), and resuspended in 100 μ\ of SM buffer [PBS plus 10 m M 
5 2 G . MacGregor, A. Mogg, J . Burke, and C . Caskey, Somatic Cell Mol. Genet. 13, 253 
(1987). 
5 3 P. Herbomel, B . Bourachot, and M. Yaniv, Cell 39, 653 (1984). 
5 4 G . P. Nolan, S. Fiering, J . F . Nicolas, and L . A. Herzenberg, Proc. Natl. Acad. Sei. 
U.S.A. 85, 2603 (1988). 
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HEPES (pH 7.3), and 4% (v/v) FCS]. The samples are transferred into 
FACS tubes and placed in a 37° water bath; 10 min later 100 μ\ of pre-
warmed 2 m M FDG [Molecular Probes, Eugene, OR; stock solution of 5 
mg FDG in 38 μ\ dimethyl sulfoxide (DMSO)/water (1/1, v/v)] in water is 
added with mixing and the samples are kept at 37° for exactly 1 min. The 
FDG loading is stopped by adding 2 ml of ice-cold SM buffer, and 2 μ\ of 
propidium iodide (1 mg/ml) is then added. The samples are kept on ice 
until FACS analysis; analysis is done with a Becton Dickinson FACScan 
at a fluorescence of 520 nm with live gating. 
A n analysis of the transfection efficiency of K562 cells using this 
method is shown in Fig. 5. K562 cells were transfected with a plasmid 
encoding the lacZ gene driven by the H I V L T R mixed with a second 
plasmid encoding the trans-activator Tat driven by the C M V promoter. 
This plasmid contains, in addition, the oriP region and the EBNA1 gene, 
which allow episomal replication of the plasmid. The FACS analysis of 
these transfected cells indicates a moderate expression of lacZ at 24 hr 
posttransfection (with 20-30% of the cells expressing detectable levels of 
the enzyme; Fig. 5A) and high expression (70-100% of the cells) at both 
48 hr and 7 days posttransfection (Fig. 5B and C). Note that this experiment 
was performed in the absence of selection; when the same cell population 
was assayed at 2 weeks posttransfection the cells displayed only back­
ground fluorescence, indicating that either the nonepisomal Tat plasmid 
or the episomal ß-Gal plasmid (or both) were lost. The FACS analysis also 
demonstrated that greater than 95% of the transfected cell population was 
viable at all times after transfection. 
Isolation of Stable Transformants 
The isolation of clones from adherent cultures is performed using 
standard techniques that need not be described here. The determination 
and isolation of stable transformants of suspension cultures is performed 
using a methylcellulose cloning procedure. Two to 3 days after transfecting 
the cells with D N A containing an appropriate selectable marker (e.g., 
neomycin phosphotransferase), aliquots of the cells are plated in a semi-
solid growth medium containing, in addition to their normal requirements, 
0.5-1 mg/ml G418 and 20 mg/ml methylcellulose (see the next section). 
Approximately 14 days later (depending on the cell type) colonies of G418-
resistant cells can be picked and transferred to suspension culture. The 
normal cloning efficiency of K652 cells using this procedure, in the absence 
of selection, is approximately 60-70% (i.e., when 100 cells are plated, 
60-70 G418-resistant colonies are obtained). 
Preparation of Methylcellulose Medium. In a 2-liter Erlenmeyer flask 
(sterile, preweighed) is placed a sterile magnetic stir bar and 460 ml of 
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sterile water. The water is heated until boiling and then 20 g of methylcellu­
lose (#64630; Fluka, Buchs, Switzerland) is added. The mixture is stirred 
for an additional 3 min and then cooled to room temperature. 
Powdered medium, sufficient for 1 liter, is placed in a 500-ml graduated 
cylinder along with the appropriate quantities of sodium bicarbonate, 
penicillin/streptomycin, and other components. The pH is checked, the 
volume is adjusted to 500 ml, and this 2 x medium is filter sterilized. The 
2 x medium is then mixed with the cooled methylcellulose solution, the 
volume is adjusted to 1 liter, and the medium is stirred at 4° overnight. 
The final medium should not be cioudy. This material is stored in 50-ml 
aliquots at - 2 0 ° . 
To prepare medium for cloning use, a 50-ml aliquot of the medium is 
thawed (normally the medium is removed to 37° the night before it is 
needed), mixed with 10 ml of serum, and the volume adjusted to 100 ml 
with complete medium lacking serum. The selective agent (e.g., G418) is 
added at this step. The material is quite viscous and the most efficient 
method of mixing is multiple inversions of a capped tube (10-15 complete 
inversions are sufficient for full dispersion of a dye marker). 
Plating Cells in Methylcellulose. A 2.5-ml aliquot of the methylcellu­
lose medium is placed in a 5-ml disposable culture tube (measurement 
is by comparison to an identical tube containing a measured 2.5-ml 
volume). A 50- to 100-μ1 aliquot of cells is added to the tube, which is 
then inverted 15 times to disperse the cells. The contents of the tube 
are then poured, in two nearly equal aliquots, into 2.5-cm culture dishes, 
of approximately 1 ml/dish. It is nearly impossible to pour the final 0.5 
ml of the viscous mixture, and this value is taken into consideration 
when aliquoting the cells. The culture dishes are then placed inside a 
large, 25 χ 25 cm culture plate that contains, in addition, several open 
dishes of sterile water that help maintain the humidity during incubation. 
The entire assembly is then placed in a 377C0 2 incubator. The methyl­
cellulose culture does not immediately attain its full viscosity, so it is 
important that the cultures be allowed to "rest" for at least 2 days 
after plating before they are moved. After that they can be carefully 
examined at 1- or 2-day intervals. Because of the spatially constrained 
nature of the cell growth, approximately twofold higher levels of G418 
are required compared to suspension cultures. At 2-3 weeks after 
plating, colonies can be harvested with a normal 20-μ1 Pipetman and 
transferred to suspension culture (normally into 100 μΐ medium in a 96-
well dish). With transferrinfection into K562 cells, approximately 0 .5 -1% 
of the transfected cells can be obtained as stable colonies. In other 
words, i f 10,000 cells are plated at 3 days posttransfection, 2 weeks 
later 50-100 colonies are obtained. 
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Concluding Remarks 
We describe here the methods for preparing and using transferrin-poly-
cation and other ligand-polycation conjugates for receptor-mediated D N A 
transfer. This method, termed transferrinfection, is particularly effective 
with cell lines derived from the erythroid lineage (e.g., K562 and HD3 
cells), most likely due to the high level of cycling transferrin receptor on 
these cells. In other established cell lines such as HeLa, CHO, Cos, 
and HepG2, this method works with efficiencies comparable to other 
transfection techniques. In certain cell types the method works poorly, or 
not at all. We are currently examining these cells to determine i f the 
problem can be remedied. 
In the cells where transferrinfection functions well, the method has the 
following advantages over other transfection methods: 
1. The method is simple to use, once the ligand-polycation conjugates 
are obtained. Unlike retroviral methods, this technique does not require 
the generation of special viral constructs. 
2. The method can be used with many D N A molecules. We have 
transfected D N A molecules from 3.5 to 15 kb with great success. 
3. The method works with high efficiency. We can demonstrate that, 
with K562 cells, 70-100% of the transfected cell population both takes up 
D N A and transiently expresses a marker gene contained on the D N A . 
We routinely obtain 0 .5-1% stable G418-resistant colony formation when 
transfecting K562 cells. 
4. The method is particularly gentle, involving a transferrin-polyca-
tion conjugate that the cell binds with nearly the same avidity as unmodi-
fied transferrin. FACS analyses of transfected cell populations demon-
strate >95% viability at 24 hr, 48 hr, and 7 days posttransfection. This 
may partly account for the high efficiencies obtained. 
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Note added in proof: Since submission of this paper there have been major develop-
ments in our understanding of the molecular mechanisms and in the procedures of 
transferrinfection. It is now suggested that the degree of gene transfer into cells is critically 
dependent on the liberation, and exit into the cytoplasm, of DNA molecules trapped in 
the endosomal compartment. The exceptional efficiency of gene transfer in K562 cells is 
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suggested to result from the extremely low endosomal pH in these cells which in turn is 
caused by a lesion in the Na + , K + -ATP regulation of endosomal acidification.1 In these 
endosomes, the weak base chloroquine is thought to accumulate to such an extent that 
it becomes osmotically active leading to disruption of the endosome and liberation of 
DNA into the cytoplasm.1 
Adenoviruses escape destruction in the lysosomal compartment because they have 
developed molecular skills to disrupt the endosome and to gain access to the cytoplasm 
through which they reach the nuclear compartment. Addition of adenovirus to the DNA-
polylysine-transferrin conjugates presumably leads to co-localization of both compounds 
in the endosome and this results in an at least 1000-fold stimulation of gene transfer 
and expression in HeLa cells 2 which are relatively poor candidates for the classical 
transferrinfection even in presence of chloroquine. Most cell lines tested respond to the 
addition of adenovirus, as long as they contain cell surface receptors for both the virus 
and for the transferrin. 
Where adenovirus receptors are lacking, cells can still be transfected at very high 
levels after chemical coupling of the adenovirus with the polylysine. Such coupling can 
be brought about either by reacting the adenovirus with polylysine in the presence of 
transglutaminase or by biotinylation of the virus and streptavidinylation of the polylysine. 1 , 3 
DNA is then added to the adenovirus-polylysine conjugate and reacted (condensed) by 
addition of polylysine-transferrin conjugate. In this way ternary complexes arise in which 
the DNA becomes ionically linked to both adenovirus-polylysine and transferrin-polylys-
ine. These conjugates have a very high capacity for transfering DNA into cells even at 
low concentration.3 In this composition DNA is transferred into the cells either via the 
transferrin or the adenovirus receptor thus extending the application of the technique to 
a great many cell types. An alternative linkage protocol is to prepare polylysine linked 
to an antibody directed against the adenovirus.4 Since in all of these ternary viral-DNA-
polylysine complexes the transfected DNA is on the outside of the adenovirus, very large 
gene constructs can be transfected.4-5 
Even where the replication deficient adenovirus dl312 is employed, the use of this virus 
in human or murine cells leads to a noticeable toxicity5 which can be recognized by cells 
rounding off and detaching from the petri dish surface. This is the reason for our lack of 
success in recording high levels of stably transformed cells using the adenovirus supported 
transfection procedure. 
Toxicity can be abolished in one of several ways. First, Ad5 dl312 can be replaced by the 
chicken C E L O adenovirus which is as endosomolytic as Ad5 (unpublished results). Second, 
it is possible to U V or psoralen inactivate the adenovirus genome.5 Such inactivated viruses 
are active in gene transfer and represent a considerable safety feature for biological (and 
medical) application. Third, endosomolytic synthetic peptides gleaned off the influenza virus 
1 E . Wagner, K . Zatloukai, M. Cotten, H . Kirlappos, K . Mechtler, D. T . Curiel, and M. L . 
Birnstiel, Proc. Natl. Acad. Sei. U.S.A. 89, 6099-6103 (1992). 
2 D. T . Curiel, S. Agarwal, E . Wagner, and M. Cotten, Proc. Natl. Acad. Sei. U.S.A. 88, 
8850-8854 (1991). 
3 K . Zatloukai, E . Wagner, M. Cotten, St. Phillips, Ch . Plank, P. Steinlein, D. Curiel, and 
M. L . Birnstiel, Annals of the New York Academy of Sciences (1992), in press. 
4 D. T . Curiel, E . Wagner, M. Cotten, M. L . Birnstiel, Ch . L i , St. Loechel, S. Agarwal, and 
P. Hu, Human Gene Therapy 3, 147-154 (1992). 
5 M. Cotten, E . Wagner, K . Zatloukai, St. Philipps, D. T . Curiel and M. L . Birnstiel, Proc. 
Nail. Acad. Sei. U.S.A. 89, 6094-6098 (1992). 
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hemagglutinin can be incorporated into DNA-polylysine-lransferrin complexes.6 Such com­
plexes represent virus-free, but virus-like entry vehicles, which work at high efficiency in 
gene transfer in a number of cells tested in our laboratory, although the efficiency of these 
vectors is not as yet as high as that obtained with complete adenovirus. 
6 E . Wagner, Ch. Plank, K. Zatloukal, M. Cotten and M. L . Birnstiel, Proc. Natl. Acad. 
Sei. U.S.A. 89, 7934-7938 (1992). 
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